| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/27/2002 | WO2002049646A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 06/27/2002 | WO2002049645A1 Therapeutic combination of amlodipine and benazepril |
| 06/27/2002 | WO2002022592A3 Substituted urea neuropeptide y y5 receptor antagonists |
| 06/27/2002 | WO2002020501A3 Polyarylcarboxamides useful as lipid lowering agents |
| 06/27/2002 | WO2002018323A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 06/27/2002 | WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same |
| 06/27/2002 | WO2001092267A3 Dihydropyridine compounds for the inhibition of calcium-influx |
| 06/27/2002 | US20020082421 Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide |
| 06/27/2002 | US20020082277 Useful in purifying these compounds from the corresponding des-fluoro impurity; making paroxetine |
| 06/27/2002 | US20020082265 For treating or preventing emphysema, cancer and dermatological disorders |
| 06/27/2002 | US20020082262 Regulate the cellular transport proteins P- glycoprotein and MRP1 , which are the proteins believed to be responsible for multidrug resistance in cancer patients |
| 06/27/2002 | CA2432638A1 Therapeutic combination of amlodipine and benazepril |
| 06/27/2002 | CA2432282A1 Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 06/26/2002 | EP1217000A1 Inhibitors of factor Xa and factor VIIa |
| 06/26/2002 | EP1216996A2 Method to synthesise biphenylyl derivatives |
| 06/26/2002 | EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 06/26/2002 | EP0888114B1 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 06/26/2002 | EP0650476B1 Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355700A 皮肤麻醉剂 Skin anesthetic |
| 06/26/2002 | CN1355162A Levo-amlodipine salt able to generate hydrate and its hydrate and preparation |
| 06/26/2002 | CN1086702C 4-hydroxy-piperidine-derivatives |
| 06/26/2002 | CN1086686C Process for preparing stereo hindered amine nitrogen-oxygen free-radical |
| 06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
| 06/25/2002 | US6410736 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 06/25/2002 | US6410735 1-(4-arylpiperazin-1-y1)-ω-[N-(α,ω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 06/25/2002 | US6410594 Viricides |
| 06/25/2002 | US6410564 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | US6410538 Benzamidine derivatives |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/20/2002 | WO2002048111A2 Method for producing 4-haloalkyl nicotine nitriles |
| 06/20/2002 | WO2002048109A2 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators |
| 06/20/2002 | WO2002048108A1 New process for the preparation diaryl-4-amino-piperidinyl compounds |
| 06/20/2002 | WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002047685A2 Nmda receptor agonist pharmaceutical compositions |
| 06/20/2002 | WO2002047679A2 Nonpeptide agonists and antagonists of vasopressin receptors |
| 06/20/2002 | WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | US20020077482 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 06/20/2002 | US20020077481 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates |
| 06/20/2002 | US20020077357 For therapy of autoimmune disease |
| 06/20/2002 | US20020077338 HIV protease inhibitors |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | DE10063008A1 Carbonsäureamidderivate Carboxamide |
| 06/20/2002 | DE10061967A1 Preparation of 4-haloalkyl-nicotinonitrile, useful as a pesticide intermediate, comprises reacting 3-amino-1-haloalkyl-2-propenone with nitrile and cyclizing the novel 3-oxo-haloalkenylamino-substituted nitrile intermediate |
| 06/20/2002 | CA2436263A1 New process for the preparation diaryl-4-amino-piperidinyl compounds |
| 06/20/2002 | CA2432825A1 Nonpeptide agonists and antagonists of vasopressin receptors |
| 06/20/2002 | CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/20/2002 | CA2431172A1 Nmda receptor antagonist pharmaceutical compositions |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214937A2 Terfenadine carboxylate and the treatment of dermal irritation |
| 06/19/2002 | EP1214589A1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 06/19/2002 | EP1214299A1 Muscarinic antagonists |
| 06/19/2002 | EP1214295A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214287A1 Amides as inhibitors for pyruvate dehydrogenase |
| 06/19/2002 | CN1354745A Ethanesulfonyl-piperidine derivatives |
| 06/19/2002 | CN1354662A Use of osanetant in pharmaceutical preparation for treatment of mood disorders |
| 06/19/2002 | CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine |
| 06/19/2002 | CN1086386C Multi-drug resistance modifier |
| 06/18/2002 | US6407235 Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
| 06/18/2002 | US6407107 4-(morpholino)alkyl butanamide derivatives; autoimmune diseases; anticarcinogenic agents |
| 06/18/2002 | US6407099 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 06/18/2002 | US6406912 Method for enzymatic enantiomer-separation of 3(r)- and 3(s)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridine or its carboxylic acid esters |
| 06/13/2002 | WO2002046159A1 Guanidine and amidine derivatives as factor xa inhibitors |
| 06/13/2002 | WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/13/2002 | WO2002046157A2 Methods for the stereoselective synthesis of substituted piperidines |
| 06/13/2002 | WO2002046156A2 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands |
| 06/13/2002 | WO2002046134A1 Novel estrogen receptor ligands and methods iii |
| 06/13/2002 | WO2002046128A2 Quaternary amino acids on solid supports |
| 06/13/2002 | WO2002018334A3 Sodium channel modulators |
| 06/13/2002 | WO2002006221A3 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 06/13/2002 | WO2001079170A3 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/13/2002 | US20020072532 Administering to animal in calcium channel blocking amount of S(-) amlodipine, or its salt free of its R(+) stereoisomer |
| 06/13/2002 | US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders |
| 06/13/2002 | US20020072517 Substituted cyclic amine metalloprotease inhibitors |
| 06/13/2002 | US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 06/13/2002 | US20020072485 Administering prior to the impairment of glucose and/or oxygen to the brain an NMDA receptor subunit (NR2B) selective NMDA antagonist to inhibit neuronal damage (ischemia) |
| 06/13/2002 | CA2431133A1 Quaternary amino acids on solid supports |
| 06/13/2002 | CA2430769A1 Novel estrogen receptor ligands and methods iii |
| 06/13/2002 | CA2429258A1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/12/2002 | EP1213281A1 Novel amide derivatives |
| 06/12/2002 | EP1213280A2 A process for the preparation of amine oxides |
| 06/12/2002 | EP1212486A1 Chlorohydrin and cationic compounds having high affinity for pulp or paper |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212300A1 Azacycloalkanone serine protease inhibitors |
| 06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/12/2002 | EP1211940A1 Azabicyclo and azacyclo oxime and amine compounds as pesticides |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0966437B1 5-aroylnaphthalene derivatives |
| 06/12/2002 | EP0934080B1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 06/12/2002 | EP0889879B1 Butadiene derivatives and process for preparing thereof |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0808314B1 Forms of paroxetin hydrochloride |
| 06/12/2002 | EP0757986B1 Arylpiperidine and arylpiperazine derivatives and drugs containing the same |
| 06/12/2002 | CN1353702A Adamantane derivatives |